Concepedia

Publication | Open Access

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

DOIFull Paper Access

144

Citations

32

References

2019

Year

Sébastien Perreault, Valérie Larouche, Uri Tabori, Cynthia Hawkin, Sarah Lippé, Benjamin Ellezam, Jean‐Claude Décarie, Yves Théorêt, Marie‐Élaine Métras, Serge Sultan,
BMC Cancer

Abstract

ClinicalTrials.gov Identifier: NCT03363217 December 6, 2017.

References

YearCitations

Page 1